| The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 176, S21-S141, 2019 | 741 | 2019 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 445 | 2021 |
| The concise guide to pharmacology 2017/18: overview SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ... British journal of pharmacology 174, S1-S16, 2017 | 308 | 2017 |
| Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice A Rizzi, R Vergura, G Marzola, C Ruzza, R Guerrini, S Salvadori, D Regoli, ... British journal of pharmacology 154 (2), 471-479, 2008 | 200 | 2008 |
| In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys (tBu) 5] neuropeptide S V Camarda, A Rizzi, C Ruzza, S Zucchini, G Marzola, E Marzola, ... Journal of Pharmacology and Experimental Therapeutics 328 (2), 549-555, 2009 | 72 | 2009 |
| Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists R Guerrini, V Camarda, C Trapella, G Calò, A Rizzi, C Ruzza, S Fiorini, ... Journal of medicinal chemistry 52 (2), 524-529, 2009 | 63 | 2009 |
| Biased versus partial agonism in the search for safer opioid analgesics J Azevedo Neto, A Costanzini, R De Giorgio, DG Lambert, C Ruzza, ... Molecules 25 (17), 3870, 2020 | 62 | 2020 |
| Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68 C Ruzza, A Rizzi, C Trapella, V Camarda, V Ruggieri, M Filaferro, C Cifani, ... Peptides 31 (5), 915-925, 2010 | 62 | 2010 |
| Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist A Rizzi, MC Cerlesi, C Ruzza, D Malfacini, F Ferrari, S Bianco, T Costa, ... Pharmacology research & perspectives 4 (4), e00247, 2016 | 54 | 2016 |
| Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor C Ruzza, A Pulga, A Rizzi, G Marzola, R Guerrini, G Calo Neuropharmacology 62 (5-6), 1999-2009, 2012 | 54 | 2012 |
| Anxiolytic‐and panicolytic‐like effects of Neuropeptide S in the mouse elevated T‐maze A Pulga, C Ruzza, A Rizzi, R Guerrini, G Calo European Journal of Neuroscience 36 (11), 3531-3537, 2012 | 49 | 2012 |
| Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands L Asth, C Ruzza, D Malfacini, I Medeiros, R Guerrini, NT Zaveri, ... Neuropharmacology 105, 434-442, 2016 | 46 | 2016 |
| Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice IU Medeiros, C Ruzza, L Asth, R Guerrini, PRT Romão, EC Gavioli, ... Peptides 72, 95-103, 2015 | 36 | 2015 |
| In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives A Rizzi, D Malfacini, MC Cerlesi, C Ruzza, E Marzola, MF Bird, ... British journal of pharmacology 171 (17), 4138-4153, 2014 | 34 | 2014 |
| Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists R Guerrini, V Camarda, C Trapella, G Caló, A Rizzi, C Ruzza, S Fiorini, ... Journal of medicinal chemistry 52 (13), 4068-4071, 2009 | 34 | 2009 |
| Synthesis and biological activity of human neuropeptide S analogues modified in position 2 V Camarda, C Trapella, G Calo′, R Guerrini, A Rizzi, C Ruzza, S Fiorini, ... Journal of medicinal chemistry 51 (3), 655-658, 2008 | 31 | 2008 |
| The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, AA Mathie, ... British journal of pharmacology 180, S23-S144, 2023 | 29 | 2023 |
| [tBu-D-Gly5] NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies C Ruzza, A Rizzi, V Camarda, A Pulga, G Marzola, M Filaferro, C Novi, ... Peptides 34 (2), 404-411, 2012 | 29 | 2012 |
| NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine VAD Holanda, WB Santos, L Asth, R Guerrini, G Calo’, C Ruzza, ... Psychopharmacology 235, 3093-3102, 2018 | 28 | 2018 |
| Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1] N/OFQ (1-13) MC Cerlesi, H Ding, MF Bird, N Kiguchi, F Ferrari, D Malfacini, A Rizzi, ... European journal of pharmacology 794, 115-126, 2017 | 27 | 2017 |
